Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
NCT01429389
This study is recruiting at 12 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Down Syndrome
- Fetal Aneuploidy
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Sequenom, Inc.
- Last updated on ClinicalTrials.gov
- September 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama Birmingham · Birmingham, AL
California · 5
- Cedars-Sinai Medical Center · Los Angeles, CA
- Sharp-Rees Stealy Medical Group · San Diego, CA
- Specialty Obstetrics of San Diego · San Diego, CA
- UCSD · San Diego, CA
- Women's Health Care Research · San Diego, CA
Illinois · 1
- Reproductive Genetics Institute · Chicago, IL
Iowa · 1
- University of Iowa Health Care · Iowa City, IA
Michigan · 2
- Henry Ford Hospital · Detroit, MI
- Spectrum Health · Grand Rapids, MI
New Jersey · 1
- The Cooper Health System · Camden, NJ
South Carolina · 1
- Medical University of South Carolina · Charleston, SC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.